The Covid-19 pandemic has exposed a series of weaknesses in the global healthcare system, making the achievement of SDG3 – good health and well-being – seem like a distant dream. Can FDI get it back on track?
Investors are seeking business resilience in the sweet spot between responsible investing and FDI amid the Covid-19 crisis.
Low tax rates, a skilled workforce and infrastructure that positions your company in the heart of major markets. Just some of the reasons Texarkana has grown to become a key site for original equipment manufacturers, as AR-TX REDI’s president and CEO Rob Sitterley explains.
AR-TX REDI
Following the Covid-19 outbreak, many governments tightened FDI regulations related to critical assets. Investment Monitor rounds up the key moves.
A report from the European Commission sets out how green hydrogen will be key to the energy transition, although it is not clear how its production will be paid for.
Partner content
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into the pandemic, the sector remains secure, but for how long will this last?
The health of the UK’s manufacturing industry was a key topic in the run-up to the country’s Brexit vote. Various sectors are coping with the twin threats of a final departure from the EU and the Covid-19 pandemic.
Canada, Mexico, and Central and Eastern Europe are identified as three key regions that investors will turn to when looking to reduce their exposure to Asia.
Developing countries will face greater challenges to restarting their economies compared with their wealthy counterparts, based on the relative sizes of their Covid-19 stimulus packages.
With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector will strongly depend on countries’ ability to respond to the epidemic, and their overall stability.
Industry leading data and analysis for the FDI community
